Elias Vamvakas

Chairman, Greybrook Capital

Elias is the Chairman and founder of Greybrook a private equity firm focused on Real Estate and Healthcare.

Elias is also Chairman of Greenbrook TMS NeuroHealth Centers (TSX: GTMS), the leading provider of TMS Therapy in North America. Greenbrook clinics provide a novel treatment for patients suffering with depression. He is also chairman of TearLab Corporation (NASDAQ/TEAR, TSX TLB), an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.

Prior to Greybrook, Elias co-founded TLCVision (NASDAQ/TLCV, TSX/TLC) where he served as President and CEO. Elias, as CEO, built TLC into the largest eye care service provider organization in North America with revenues of more than $300,000,000 as TLC opened or acquired more than 100 laser eye clinics, over 200 mobile laser sites, more than 250 mobile cataract locations several ambulatory surgery centers and through its subsidiary Vision Source Inc. developed the largest independent Optometric Franchise with more than 2,000 locations. TLC’s stock, listed on the TSX and NASDAQ since 1996, appreciated to well over $1 Billion during his tenure.

Elias has received many management awards from industry and his peers including.

Canada’s Top Forty under Forty” in 1996.
-an award that recognizes the top 40 Canadians under the age of 40.

In 1999, Elias received the Presidential Medal of Honor from the Illinois College of Optometry.

In 1999 he was named Ernst & Young’s Canadian Entrepreneur of the Year for Innovative Partnering and Entrepreneur of the Year for Ontario in the Emerging Category.

In 2000, Elias was recognized by Profit Magazine for managing Canada’s fastest growing company (TLC) with over 25,000% growth over 5 years.

In 2005 he was also voted “best of the best” by his peers.